Caio Max S. Rocha Lima, M.D.
Associate Professor of Clinical Medicine
Description of Research
Dr. Rocha Lima’s research interests focus on the following areas: development and conducting of clinical trials, translational research, new drug development in cancer, tumor phenotype profiling as a prognosticator (collaborations with research labs in Genomics and Proteomics), and pharmacogenomics: SNPs (Nucleotide Polymorphism) and chemotherapy toxicity. His work is concentrated mainly in lung cancer and gastrointestinal malignancies.
- IrinoGem (Gemcitabine and Irinotecan in combination) for pancreatic cancer and lung cancer (both small and non-small cell lung cancer)
- DocGem in lung cancer
- ETopoTax in small cell lung cancer
Selected Cancer-Related Publications
- Ascunce G, Ribeiro A, Reis I, Rocha-Lima C, Sleeman D, Merchan J, Levi J. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc 73:267-74, 2011. Read more »
- Ascunce G, Ribeiro A, Rocha-Lima C, Larsen M, Sleeman D, Merchan J, Szabo D, Levi JU. Single-session endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography for evaluation of pancreaticobiliary disorders. Surg Endosc 24:1447-50, 2010. Read more »
- Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee JH, Bloom G, Rocha-Lima C, Kelley S, Calvin DP, Yeatman TJ, Begg AC, Torres-Roca JF. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys 75:489-96,2009. Read more »
Collaborating in the Multidisciplinary Research Program(s):